SUL-238, a first-in-class medicine, protects from ageing

by | Oct 21, 2024 | News

We are happy to share great news! SUL-238 is currently in Phase I clinical trials in collaboration with our Turkish partner GEN Ilac. It is the first drug reported that leads to persisting improvement of vascular aging. This work has recently been published in The...

SUL-238 featured in Nature Medicine

by | Sep 10, 2024 | News

We are excited to announce that our lead drug candidate SUL-238 has been featured in the prestigious journal Nature Medicine. The article highlights hibernation as a source of inspiration for drug development, which also forms the basis for our groundbreaking...

Wintersleep as medicine?

by | May 17, 2024 | News

Wintersleep or hibernation is used by some animals to survive harsh environmental conditions, but not all animals can hibernate. Interestingly, hibernators possess protective mechanisms that allows them to withstand or repair cell and organ damage that develops during...